We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
AUM
$6.59B
AUM Growth
-$836M
Cap. Flow
-$48.4M
Cap. Flow %
-0.73%
Top 10 Hldgs %
15.06%
Holding
1,801
New
509
Increased
232
Reduced
294
Closed
676

Sector Composition

Rank Sector Weight
1 Miscellaneous 87.61%
2 Healthcare 2.74%
3 Communication Services 2.58%
4 Financials 2.16%
5 Technology 1.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INBX
1801
CALL
DELISTED
Inhibrx, Inc. Common Stock
INBX
-175,400
Closed -$6.67M

Similar funds

Caption Management's Q1 2024 Portfolio in Review

As of Q1 2024, Caption Management held 1,801 positions worth $6.59B, down 11% from $7.42B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Caption Management's Q1 2024 filing shows 509 new, 232 increased, 294 reduced and 676 closed positions. Its largest new stake was Adobe: 22,800 shares worth $11.5M. The largest sale was Apellis Pharmaceuticals, an estimated $23.1M.

By sector, the portfolio is most concentrated in Miscellaneous at 88% of assets, down from 89% a quarter earlier, followed by Healthcare and Communication Services.

  • Caption Management's largest Q1 2024 buy was Adobe: 22,800 shares worth $11.5M.
  • Caption Management added most to Sarepta Therapeutics in Q1 2024, an estimated $18.4M increase.
  • Caption Management's biggest Q1 2024 reduction was Apellis Pharmaceuticals, cutting an estimated $23.1M.
  • Caption Management fully exited Palo Alto Networks in Q1 2024, selling an estimated $20.9M.
  • Caption Management's ten largest holdings make up 15% of its $6.59B portfolio in Q1 2024.
  • Caption Management opened 509 new positions and closed 676 in Q1 2024.
  • Caption Management's portfolio value fell 11% quarter-over-quarter to $6.59B.

Based on Caption Management's 13F filing for Q1 2024, filed 15 May 2024.